Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas W Wastesson

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Journal of the American Geriatrics Society|December 22, 2018
How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort StudyJonas W Wastesson, Lucas Morin, Marie-Laure Laroche, et al.
Scandinavian Journal of Public Health|November 13, 2014
Inequalities in health care use among older adults in Sweden 1992-2011: a repeated cross-sectional study of Swedes aged 77 years and olderJonas W Wastesson, Stefan Fors, Marti G Parker, et al.
Journal of the American Geriatrics Society|May 9, 2024
Spousal bereavement and four-year trajectories of medication use: A nationwide register-based study in Swedish older adultsGéric Maura, Pierre-Olivier Blotière, Jonas W Wastesson, et al.
Expert Opinion on Drug Safety|December 13, 2018
An update on the clinical consequences of polypharmacy in older adults: a narrative reviewJonas W Wastesson, Lucas Morin, Edwin C K Tan, et al.
Frontiers in Pharmacology|February 27, 2023
Regional variations in excessive polypharmacy and potentially inappropriate drug use among older adults in Sweden: Trends from 2006 to 2020Jonas W Wastesson, Johan Fritzell, Bo Burström, et al.
Basic & Clinical Pharmacology & Toxicology|October 13, 2025
Studying Deprescribing Using Routinely Collected Healthcare Data: Old Challenges and New OpportunitiesJonas W Wastesson, Karl-Hermann Sielinou Kamgang, Carina Lundby, et al.
Cancer|July 11, 2019
Reply to Deprescription during last year of life in patients with pancreatic cancer: Optimization or nihilism?Lucas Morin, Stephen Barclay, Jonas W Wastesson, et al.
Journal of Epidemiology and Community Health|February 21, 2018
Gender differences in the use of anti-infective medications before and after widowhood: a register-based studyAdriana Santacroce, Jonas W Wastesson, Andreas Höhn, et al.
Scandinavian Journal of Public Health|December 30, 2021
Increasing inequalities in disability-free life expectancy among older adults in Sweden 2002-2014Louise Sundberg, Neda Agahi, Jonas W Wastesson, et al.
Journal of the American Medical Directors Association|September 6, 2015
Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and OlderJonas W Wastesson, Vladimir Canudas-Romo, Rune Lindahl-Jacobsen, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Journal of the American Geriatrics Society|December 22, 2018
How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort StudyJonas W Wastesson, Lucas Morin, Marie-Laure Laroche, et al.
Scandinavian Journal of Public Health|November 13, 2014
Inequalities in health care use among older adults in Sweden 1992-2011: a repeated cross-sectional study of Swedes aged 77 years and olderJonas W Wastesson, Stefan Fors, Marti G Parker, et al.
Journal of the American Geriatrics Society|May 9, 2024
Spousal bereavement and four-year trajectories of medication use: A nationwide register-based study in Swedish older adultsGéric Maura, Pierre-Olivier Blotière, Jonas W Wastesson, et al.
Expert Opinion on Drug Safety|December 13, 2018
An update on the clinical consequences of polypharmacy in older adults: a narrative reviewJonas W Wastesson, Lucas Morin, Edwin C K Tan, et al.
Frontiers in Pharmacology|February 27, 2023
Regional variations in excessive polypharmacy and potentially inappropriate drug use among older adults in Sweden: Trends from 2006 to 2020Jonas W Wastesson, Johan Fritzell, Bo Burström, et al.
Basic & Clinical Pharmacology & Toxicology|October 13, 2025
Studying Deprescribing Using Routinely Collected Healthcare Data: Old Challenges and New OpportunitiesJonas W Wastesson, Karl-Hermann Sielinou Kamgang, Carina Lundby, et al.
Cancer|July 11, 2019
Reply to Deprescription during last year of life in patients with pancreatic cancer: Optimization or nihilism?Lucas Morin, Stephen Barclay, Jonas W Wastesson, et al.
Journal of Epidemiology and Community Health|February 21, 2018
Gender differences in the use of anti-infective medications before and after widowhood: a register-based studyAdriana Santacroce, Jonas W Wastesson, Andreas Höhn, et al.
Scandinavian Journal of Public Health|December 30, 2021
Increasing inequalities in disability-free life expectancy among older adults in Sweden 2002-2014Louise Sundberg, Neda Agahi, Jonas W Wastesson, et al.
Journal of the American Medical Directors Association|September 6, 2015
Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and OlderJonas W Wastesson, Vladimir Canudas-Romo, Rune Lindahl-Jacobsen, et al.
Pageof 6